For: | Yousef MH, Al Juboori A, Albarrak AA, Ibdah JA, Tahan V. Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients. World J Gastrointest Pathophysiol 2017; 8(3): 100-107 [PMID: 28868179 DOI: 10.4291/wjgp.v8.i3.100] |
---|---|
URL: | https://www.wjgnet.com/2150-5330/full/v8/i3/100.htm |
Number | Citing Articles |
1 |
Walee Chamulitrat, Gerhard Liebisch, Anita Pathil, Wolfgang Stremmel. Dietary Interventions in Liver Disease. 2019; : 239 doi: 10.1016/B978-0-12-814466-4.00020-3
|
2 |
Asad Mirzaei, Asma Asal, Ali Seidkhani-Nahal, Ali Noori-Zadeh. A systematic review and meta-analysis of serum resistin level and its relation to HOMA-IR score using meta-regression in nonalcoholic fatty liver disease patients. Mediterranean Journal of Nutrition and Metabolism 2021; 14(3): 219 doi: 10.3233/MNM-210538
|
3 |
Syed Messum Ali Kazmi, Rabia Iftikhar. Biopsychosocial Determinants of Quality of Life in Patients with Hepatitis B and C. Pakistan Journal of Health Sciences 2023; : 85 doi: 10.54393/pjhs.v4i10.1077
|
4 |
Yin Li, Hui Chen, Zunli Ke, Jinwen Huang, Leilei Huang, Baican Yang, Shengjie Fan, Cheng Huang. Identification of isotschimgine as a novel farnesoid X receptor agonist with potency for the treatment of obesity in mice. Biochemical and Biophysical Research Communications 2020; 521(3): 639 doi: 10.1016/j.bbrc.2019.10.169
|
5 |
Ekrem Aksu, Abdullah Sokmen, Murat Ispiroglu, Kadir Gisi, Enes Celik, Ahmet Cagri Aykan. Early cardiac electrical and structural changes in patients with non-obese non-alcoholic fatty liver disease. Kardiologiia 2021; 61(5): 51 doi: 10.18087/cardio.2021.5.n1416
|
6 |
Roman Liebe, Marcin Krawczyk. Nicht-alkoholische Fettlebererkrankung. 2022; : 335 doi: 10.1007/978-3-662-62484-5_29
|
7 |
Emilio Molina-Molina, Marcin Krawczyk, Ewa Stachowska, Frank Lammert, Piero Portincasa. Non-Alcoholic Fatty Liver Disease in Non-Obese Individuals: Prevalence, Pathogenesis and Treatment. Clinics and Research in Hepatology and Gastroenterology 2019; 43(6): 638 doi: 10.1016/j.clinre.2019.04.005
|
8 |
Xintian Cai, Xiayire Aierken, Ayguzal Ahmat, Yuanyuan Cao, Qing Zhu, Ting Wu, Nanfang Li, Marcello Maida. A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/8852198
|
9 |
Weimin Guo, Dayong Wu, Maria C Dao, Lijun Li, Erin D Lewis, Edwin F Ortega, Heesun Eom, Michael Thomas, Mariana Nikolova-Karakashian, Mohsen Meydani, Simin N Meydani. A Novel Combination of Fruits and Vegetables Prevents Diet-Induced Hepatic Steatosis and Metabolic Dysfunction in Mice. The Journal of Nutrition 2020; 150(11): 2950 doi: 10.1093/jn/nxaa259
|
10 |
Phei Oon Tan, Nazri Mustaffa, Soek Siam Tan, Yeong Yeh Lee. Diagnosis and Management of Fatty Liver. Journal of the Royal College of Physicians of Edinburgh 2020; 50(3): 256 doi: 10.4997/jrcpe.2020.308
|
11 |
Isabel Hidalgo, Miguel Ortiz-Flores, Francisco Villarreal, Salvador Fonseca-Coronado, Guillermo Ceballos, Eduardo Meaney, Nayelli Nájera. Is it possible to treat nonalcoholic liver disease using a flavanol-based nutraceutical approach? Basic and clinical data. Journal of Basic and Clinical Physiology and Pharmacology 2022; 33(6): 703 doi: 10.1515/jbcpp-2021-0285
|
12 |
Walee Chamulitrat, Chutima Jansakun, Huili Li, Gerhard Liebisch. Rescue of Hepatic Phospholipid Remodeling Defect in iPLA2β-Null Mice Attenuates Obese but Not Non-Obese Fatty Liver. Biomolecules 2020; 10(9): 1332 doi: 10.3390/biom10091332
|
13 |
Oren Tirosh, Anna M. Giudetti. Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/2548154
|
14 |
Anita Krishnarao, Carmi S. Punzalan. National and Global Ethnicity Differences in Non-alcoholic Fatty Liver Disease. Current Hepatology Reports 2020; 19(4): 429 doi: 10.1007/s11901-020-00552-8
|
15 |
Young Eun Chon, Hyung Jong Kim, Yu Bum Choi, Seong Gyu Hwang, Kyu Sung Rim, Mi Na Kim, Joo Ho Lee, Yeonjung Ha, Mi Jung Lee. Decrease in waist-to-hip ratio reduced the development of chronic kidney disease in non-obese non-alcoholic fatty liver disease. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65940-y
|
16 |
Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Elena Shirokova, Kirill M Starostin. Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia. BMJ Open Gastroenterology 2019; 6(1): e000307 doi: 10.1136/bmjgast-2019-000307
|
17 |
Emma Purón-González, Arnulfo González-Cantú, Edgar Ulises Coronado-Alejandro, Oswaldo Enrique Sánchez-Dávila, Héctor Cobos-Aguilar, Maria Elena Romero-Ibarguengoitia. Predictive markers of nonalcoholic fatty liver disease in lean patients. A multinomial regression model and a 2k factorial analysis. European Journal of Gastroenterology & Hepatology 2021; 33(10): 1316 doi: 10.1097/MEG.0000000000001845
|
18 |
Haofei Hu, Changchun Cao, Yong Han, Yongcheng He. Triglyceride affects the association between estimated glomerular filtration rate and the onset of non-alcoholic fatty liver disease: A second analysis of a Chinese cohort study. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.984241
|
19 |
Sahar Y. Al-Okbi, Doha A. Mohamed, Thanaa E. Hamed, Ahmed M.M. Gabr, Hoda B. Mabrok, Shaimaa E. Mohammed, Oksana Sytar. Buckwheat Treatment Ameliorates Transforming Growth Factor Beta-1, its Receptor Gene Expression and Biochemical Parameters in Experimental Steatohepatitis. International Journal of Botany 2018; 15(1): 5 doi: 10.3923/ijb.2019.5.13
|
20 |
Yoon Jin Choi, Dong Ho Lee, Kyung-Do Han. Association between high fatty liver index and development of colorectal cancer: a nationwide cohort study with 21,592,374 Korean. The Korean Journal of Internal Medicine 2020; 35(6): 1354 doi: 10.3904/kjim.2018.022
|
21 |
Oleg BABAK, Kateryna LAPSHYNA, Konstantyn PROSOLENKO, Arkadiy CHERNYAK, Olena GOPTSIY. Evaluation of MACK-3 parameters, metabolic and fibrotic characteristics of non-alcoholic fatty liver disease patients with hypertension. Minerva Gastroenterology 2022; 68(4) doi: 10.23736/S2724-5985.21.02982-X
|